Seeking Alpha

Hospira (HSP +3.7%) shares surge on a report that a U.S. district court invalidated...

Hospira (HSP +3.7%) shares surge on a report that a U.S. district court invalidated Sanofi-Aventis' (SNY -2.1%) patent on Taxotere, potentially opening the door for its generic version of the cancer treatment. The drug was one of Sanofi's top revenue producers, with $2.2B in sales in 2009.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|